The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange
Kerrin Hansen, Ivo R. Ruttekolk, Heike Glauner, Frank Becker, Roland Brock, Stefan HannusVolume:
46
Year:
2009
Language:
english
DOI:
10.1016/j.molimm.2009.07.031
File:
PDF, 1.71 MB
english, 2009